The mechanism by which NF1 loss abrogates ERK to RAF feedback in neuroblastoma cells harboring ALK mutations remains elusive, but this will not prevent a rapid translation of this collateral sensitivity into the clinic. Here, NF1 is linked to neuroblastoma.